Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

405 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Using non-coding small RNAs to develop therapies for Huntington's disease.

Zhang Y, Friedlander RM.

Gene Ther. 2011 Dec;18(12):1139-49. doi: 10.1038/gt.2011.170. Review.

0

0

0

PUBMED

The Wilson films--Sydenham chorea.

Cardoso F.

Mov Disord. 2011 Dec;26(14):2477-8. doi: 10.1002/mds.24032. No abstract available.

0

0

0

PUBMED

Potential drugs and methods for preventing or delaying the progression of Huntington's disease.

Sari Y.

Recent Pat CNS Drug Discov. 2011 May 1;6(2):80-90.

0

0

0

PUBMED

Recombinant Intrabodies as Molecular Tools and Potential Therapeutics for Huntington’s Disease.

Ali K, Southwell AL, Bugg CW, Ko JC, Patterson PH.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 10.

0

0

0

PUBMED

Palliative care for patients with Huntington's disease #201.

Marks S, Hung S, Rosielle DA.

J Palliat Med. 2011 May;14(5):655-6. doi: 10.1089/jpm.2011.9696. No abstract available.

0

0

0

PUBMED

Chorea in systemic lupus erythematosus.

Baizabal-Carvallo JF, Alonso-Juarez M, Koslowski M.

J Clin Rheumatol. 2011 Mar;17(2):69-72. doi: 10.1097/RHU.0b013e31820e7c8d.

0

0

0

PUBMED

Pharmaceutical Development for Huntington’s Disease.

Morse RJ, Leeds JM, Macdonald D, Park L, Toledo-Sherman L, Pacifici R.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 8.

0

0

0

PUBMED

Post-streptococcal chorea in an adult with bilateral striatal encephalitis.

Hagiwara K, Tominaga K, Okada Y, Kido M, Yamasaki R, Shida N, Yamashita Y.

J Clin Neurosci. 2011 May;18(5):708-9. doi: 10.1016/j.jocn.2010.08.024.

0

0

0

PUBMED

Meclizine is neuroprotective in models of Huntington's disease.

Gohil VM, Offner N, Walker JA, Sheth SA, Fossale E, Gusella JF, MacDonald ME, Neri C, Mootha VK.

Hum Mol Genet. 2011 Jan 15;20(2):294-300. doi: 10.1093/hmg/ddq464.

0

0

0

PUBMED

Hunting biomarkers for Huntington's disease: H2AFY.

Lake F.

Biomark Med. 2011 Dec;5(6):817-20. doi: 10.2217/bmm.11.95. No abstract available.

0

0

0

PUBMED

Incidence, course, and predictors of apathy in Huntington's disease: a two-year prospective study.

Reedeker N, Bouwens JA, van Duijn E, Giltay EJ, Roos RA, van der Mast RC.

J Neuropsychiatry Clin Neurosci. 2011 Fall;23(4):434-41. doi: 10.1176/appi.neuropsych.23.4.434.

0

0

0

PUBMED

Cell-based treatments for huntington's disease.

Dunnett SB, Rosser AE.

Int Rev Neurobiol. 2011;98:483-508. doi: 10.1016/B978-0-12-381328-2.00017-1. Review.

0

0

0

PUBMED

Assessment of cognitive symptoms in prodromal and early huntington disease.

Vaccarino AL, Sills T, Anderson KE, Borowsky B, Craufurd D, Giuliano J, Goodman L, Guttman M, Kupchak P, Ho AK, Paulsen JS, C Stout J, van Kammen DP, Evans K.

PLoS Curr. 2011 Oct 25;3:RRN1250.

0

0

0

PUBMED

Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease.

Kandasamy M, Reilmann R, Winkler J, Bogdahn U, Aigner L.

Neurol Res Int. 2011;2011:124256. doi: 10.1155/2011/124256.

0

0

0

PUBMED

High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model.

Schulte J, Sepp KJ, Wu C, Hong P, Littleton JT.

PLoS One. 2011;6(8):e23841. doi: 10.1371/journal.pone.0023841.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy